C4 Therapeutics (CCCC) Change in Accrued Expenses (2019 - 2026)
C4 Therapeutics (CCCC) posted Change in Accured Expenses of $3.99 million for Q2 2026, up 536.8% from $627,000 a year earlier.
Powered by 
Analysis
C4 Therapeutics (CCCC) Change in Accrued Expenses (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at C4 Therapeutics was $525,000, down 74.3% year-over-year; for FY2025, it was -$6.05 million.
- In prior years, C4 Therapeutics' Change in Accured Expenses was -$1.27 million in FY2024, $1.32 million in FY2023 (-74.1%), $5.08 million in FY2022 (+16.1%) and $4.38 million in FY2021 (+71.1%).
- The Q2 2026 figure stands as the highest quarterly Change in Accured Expenses since Q3 2024.
- The strongest year-over-year quarter for Change in Accured Expenses in the past five years was Q2 2026, with growth of 536.8%; the weakest was Q2 2023, with a decline of 85.4%.
- According to Business Quant data, Change in Accured Expenses for the three prior quarters was -$3.52 million (Q1 2026), $2.07 million (Q4 2025) and -$2.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | C4 Therapeutics | 393.93 Mn | -549.34 Mn | - | 357,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 357,000.00 |
| Jun 30, 2026 | 3.99 Mn |
| Mar 31, 2026 | -3.52 Mn |
| Dec 31, 2025 | 2.07 Mn |
| Sep 30, 2025 | -2.02 Mn |
| Jun 30, 2025 | 627,000.00 |
| Mar 31, 2025 | -6.73 Mn |
| Dec 31, 2024 | 3.98 Mn |
| Sep 30, 2024 | 4.17 Mn |
| Jun 30, 2024 | -1.75 Mn |
| Mar 31, 2024 | -7.66 Mn |
| Dec 31, 2023 | 5.18 Mn |
| Sep 30, 2023 | -733,000.00 |
| Jun 30, 2023 | 537,000.00 |
| Mar 31, 2023 | -3.67 Mn |
| Dec 31, 2022 | 2.69 Mn |
| Sep 30, 2022 | 2.48 Mn |
| Jun 30, 2022 | 3.68 Mn |
| Mar 31, 2022 | -3.77 Mn |
| Dec 31, 2021 | 2.14 Mn |
API Access
C4 Therapeutics Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CCCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "CCCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CCCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();